BRWA
LSTA icon

B. Riley Wealth Advisors’s Lisata Therapeutics LSTA Stock Holding History

B. Riley Wealth Advisors’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-24
Closed -$14 – 1367
2014
Q4 		$14 Buy
+24
New +$16.3K ﹤0.01% 2702
2014
Q3 		– Sell
-24
Closed -$23.5K – 1352
2014
Q2 		$23.5K Buy
+24
New +$23.3K 0.01% 1401

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

B. Riley Wealth Advisors's LSTA Position: Q1 2015 in Review

B. Riley Wealth Advisors sold out of Lisata Therapeutics (LSTA) in Q1 2015, closing a stake of 24 shares — an estimated $14 sold.

B. Riley Wealth Advisors first reported a position in LSTA in Q2 2014 and held it in 2 quarters. The position peaked at $23.5K in Q2 2014. 52 funds tracked by Wall St. Rank hold LSTA as of Q1 2015.

  • B. Riley Wealth Advisors reported no remaining Lisata Therapeutics position as of Q1 2015 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 24 Lisata Therapeutics shares in Q1 2015, an estimated $14.
  • B. Riley Wealth Advisors first reported a position in Lisata Therapeutics in Q2 2014 and held it in 2 quarters.
  • B. Riley Wealth Advisors's Lisata Therapeutics position peaked at $23.5K in Q2 2014.
  • 52 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2015.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2015, filed 14 May 2015.